Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease.

Author: Xin ZHANG ¹ ; Xiaojuan YU ¹ ; Suxia WANG ¹ ; Yujun DONG ² ; Minghui ZHAO ¹ ; Fude ZHOU ¹
Author Information

1. Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China.
2. Hematological Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China.
Publication Type:Journal Article
From: Chinese Medical Journal 2025;138(2):246-248
CountryChina
Language:English